Literature DB >> 11136875

Association of markers for TGFbeta3, TGFbeta2 and TIMP1 with systemic sclerosis.

E Susol1, A L Rands, A Herrick, N McHugh, J H Barrett, W E Ollier, J Worthington.   

Abstract

OBJECTIVES: To investigate whether six microsatellite markers known to map closely to genes involved in fibrosis are associated with systemic sclerosis (SSc).
METHODS: Markers mapping to TGFbeta1, TGFbeta2, TGFbeta3, PDGFB, TIMP1 and COL5A2 were genotyped and allele frequency distributions compared in 191 patients and 196 controls. As TIMP1 maps to the X chromosome, male and females were analysed separately. Markers associated with SSc were further investigated according to whether patients had limited (lcSSc) or diffuse (dcSSc) cutaneous fibrosis.
RESULTS: Associations were found between SSc and markers for TGFbeta3 (chi(2)=17.3, df=8, P=0.02), TGFbeta2 (chi(2)=25.2, df=13, P=0.02) and TIMP1 (with male SSc, chi(2)=11.9, df=5, P=0.03), between lcSSc and the TGFss2 marker (chi(2)=25.6, df=13, P=0.02), and between dcSSc and TGFbeta3 marker (chi(2)=27.1, df=8, P=0.001). Between lcSSc and dcSSc patients, the allele frequency distribution differed only for the TGFbeta3 marker (chi(2)=16.5, df=6, P=0.01).
CONCLUSION: These associations indicate a possible role for TGFbeta3, TGFbeta2 and TIMP1 in genetic susceptibility to SSc and for TGFbeta3 in determining the degree of cutaneous fibrosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11136875     DOI: 10.1093/rheumatology/39.12.1332

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  12 in total

Review 1.  The genetics of systemic sclerosis.

Authors:  Randall W Johnson; Monty B Tew; Frank C Arnett
Journal:  Curr Rheumatol Rep       Date:  2002-04       Impact factor: 4.592

Review 2.  Apoptosis and myofibroblasts in the pathogenesis of systemic sclerosis.

Authors:  Eugene Kissin; Joseph H Korn
Journal:  Curr Rheumatol Rep       Date:  2002-04       Impact factor: 4.592

3.  Analysis of TIMP-1 gene polymorphisms in Italian sclerodermic patients.

Authors:  Manuela Indelicato; Valentina Chiarenza; Massimo Libra; Grazia Malaponte; Valentina Bevelacqua; Maurizio Marchini; James A McCubrey; Franca Stivala; Raffaella Scorza; Maria Clorinda Mazzarino
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

4.  Ligand-dependent genetic recombination in fibroblasts : a potentially powerful technique for investigating gene function in fibrosis.

Authors:  Bing Zheng; Zhaoping Zhang; Carol M Black; Benoit de Crombrugghe; Christopher P Denton
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

Review 5.  Genetics and proteomics in scleroderma.

Authors:  Carol A Feghali-Bostwick
Journal:  Curr Rheumatol Rep       Date:  2005-04       Impact factor: 4.592

6.  The Immunogenetics of Systemic Sclerosis.

Authors:  Begüm Ünlü; Ümit Türsen; Zeynab Rajabi; Navid Jabalameli; Fateme Rajabi
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 7.  Challenges and opportunities in treating inflammation associated with pulmonary hypertension.

Authors:  Norbert F Voelkel; Rasa Tamosiuniene; Mark R Nicolls
Journal:  Expert Rev Cardiovasc Ther       Date:  2016-05-04

8.  [Therapeutic effect of enhancer of Zeste homolog 2 inhibitor GSK343 on periodontitis by regulating macrophage differentiation].

Authors:  Wang Zhongchao; Fan Liyuan; Tan Dan; Zhou Cong; Luo Shijun
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2017-06-01

Review 9.  Genetic epidemiology: systemic sclerosis.

Authors:  Ariane L Herrick; Jane Worthington
Journal:  Arthritis Res       Date:  2002-01-16

10.  Sarcoidosis and Systemic Sclerosis: Strange Bedfellows.

Authors:  Micah Yu; Vaneet K Sandhu; Sheila D Lezcano; Kanwaljeet Maken; Shannon Kirk; Karina D Torralba
Journal:  Case Rep Rheumatol       Date:  2017-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.